Inventor
VAN DER STAAY FRANZ-JOSEF
NL25 patents
⚠️ This page may combine multiple inventors who share the name “VAN DER STAAY FRANZ-JOSEF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER AG
10 patentsUS6573263B2Jun 3, 2003
Substituted imidazotriazinones
BAYER AG29 citations92
US5874438AFeb 23, 1999
2,2'-bridged bis-2,4-diaminoquinazolines
BAYER AG57 citations92
US5866562AFeb 2, 1999
Ring-bridged bis-quinolines
BAYER AG55 citations92
US5760230AJun 2, 1998
4, 4'-bridged bis-2, 4-diaminoquinazolines
BAYER AG38 citations92
US6589949B1Jul 8, 2003
3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases
BAYER AG23 citations91
US5739127AApr 14, 1998
2,4'-bridged bis-2,4-diaminoquinazolines
BAYER AG36 citations91
US6998402B2Feb 14, 2006
Substituted imidazotriazinones
BAYER AG11 citations83
US5756517AMay 26, 1998
Use of bisquinoline compounds in the treatment of cerebral disorders
BAYER AG18 citations83
US6174897B1Jan 16, 2001
Bis-(quinolyl)-diamines
BAYER AG10 citations73
US6344471B1Feb 5, 2002
2-aminocarbonyl-5(2H)-isoxazolones as ligands of a DFP-binding site treatment of CNS-diseases
BAYER AG0 citations38
BAYER IP GMBH
4 patentsUS10214524B2Feb 26, 2019
2-heteroaryl carboxamides
BAYER IP GMBH1 citations62
US9714242B2Jul 25, 2017
Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
BAYER IP GMBH1 citations62
US9067931B2Jun 30, 2015
2-heteroaryl carboxamides
BAYER IP GMBH2 citations62
US10196388B2Feb 5, 2019
Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
BAYER IP GMBH0 citations51
BOEHRINGER INGELHEIM INT
3 patentsUS7615558B2Nov 10, 2009
6-arylmethylprazolo[3,4-d]pyrimidines
BOEHRINGER INGELHEIM INT31 citations92
US7488733B2Feb 10, 2009
6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
BOEHRINGER INGELHEIM INT37 citations92
US8044060B2Oct 25, 2011
6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
BOEHRINGER INGELHEIM INT11 citations84
HENDRIX MARTIN
3 patentsUS8822479B2Sep 2, 2014
6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
HENDRIX MARTIN0 citations51
US8642605B2Feb 4, 2014
6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
HENDRIX MARTIN0 citations51
US8809348B2Aug 19, 2014
6-arylmethyl substituted pyrazolo[3,4-d]pyrimidines
HENDRIX MARTIN1 citations48